Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer
Epithelial ovarian cancer is predominantly diagnosed at advanced stages which creates significant therapeutic challenges. As a result, the 5-year survival rate is low. Within ovarian cancer, significant tumor heterogeneity exists, and the tumor microenvironment is diverse. Tumor heterogeneity leads...
Enregistré dans:
Auteurs principaux: | Madison Pereira, Kathy Matuszewska, Colin Jamieson, Jim Petrik |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ef36c2a4f82442c6839a11c27f7ad561 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Endocrine Disorders and Genital Infections Impair Gynecological Health in APECED (APS-1)
par: Viivi Saari, et autres
Publié: (2021) -
Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma
par: Marta Opalińska, et autres
Publié: (2021) -
Premature ovarian failure could be an alarming sign of polyglandular autoimmune dysfunction
par: Saif Aasem, et autres
Publié: (2017) -
Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2
par: Anna Reimer Hansen, et autres
Publié: (2021) -
Metabolomic Profiling of Poor Ovarian Response Identifies Potential Predictive Biomarkers
par: Haixia Song, et autres
Publié: (2021)